Delivery Order SPE2DB24D2205-SPE2DB25FECRL

Award Date 5/20/25
Potential Completion Date 6/11/25
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,771.74, is for the supply of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,771.74 contract is for the delivery of OFEV 150 MG CAPSULE 60S, a medication, with a completion date of June 6, 2025. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,220.86, is for the delivery of 60-count packages of the medication OFEV 100 MG CAPSULE. The contract has an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,771.74 firm-fixed-price contract is for the supply of OFEV 150 MG capsules. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside requirement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,590.58 contract is for the supply of OFEV 150 MG CAPSULE 60S, a specialized pharmaceutical product. The contract has a performance period through February 18, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,590.58 firm fixed price contract is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product. The contract has a period of performance through June 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a $8,630.28 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of OFEV 100 MG CAPSULE 60S. The contract has an ultimate completion date of April 21, 2025. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,630.28, is for the supply of OFEV 100 MG CAPSULE 60S, a specialty medication. The contract has an ultimate completion date of April 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OFEV 150 MG CAPSULE 60S, a pharmaceutical product, with a firm fixed price ceiling value of $8,590.58 and a completion date of June 10, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $7,905.56 contract is for the delivery of OFEV 150 MG CAPSULE 60S, a specialty pharmaceutical product, with a performance period through April 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FECRL
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,771.74, is for the delivery of OFEV 150 MG CAPSULE 60S and has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp also holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The contract has no set-aside designation, indicating open competition.

Generated 8/24/25, 1:05 AM